FDA Grants First Marketing Authorization for a DNA Test to Assess Predisposition for Dozens of Cancer Types

SILVER SPRING, Md., Sept. 29, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration granted de novo marketing authorization for the Invitae Common Hereditary Cancers Panel, an in vitro diagnostic test that can help detect hundreds of genetic variants associated with an…